Literature DB >> 4040375

Catalase mediated conversion of cyanamide to an inhibitor of aldehyde dehydrogenase.

E G DeMaster, F N Shirota, H T Nagasawa.   

Abstract

A minor pathway for cyanamide metabolism catalyzed by catalase is responsible for the conversion of cyanamide to an inhibitor of aldehyde dehydrogenase. Catalase itself is also inhibited by cyanamide. Both the activation of cyanamide by catalase and the inhibition of catalase by cyanamide were blocked in vivo by ethanol pretreatment, suggesting that these two processes are closely linked. Like other catalase oxidation reactions, the catalase mediated activation of cyanamide was inhibited by 3-amino-1,2,4-triazole in vivo and sodium azide in vitro. The relative formation of the active cyanamide metabolite was assessed in vitro by following the loss of yeast aldehyde dehydrogenase activity with time. Inhibition of the yeast enzyme by activated cyanamide was dependent on NAD+ or NADP+, a requirement not fulfilled by NADH or NADPH. Although H2O2 inhibited yeast aldehyde dehydrogenase in vitro and cyanamide inhibited hepatic catalase in vivo, the possible in hepatic H2O2 concentration following cyanamide administration does not account for the effects of cyanamide on ethanol metabolism. While the cyanamide activating enzyme has been identified as catalase, the reaction products of this reaction and, in particular, the structure of the active metabolite involved in the inhibition of aldehyde dehydrogenase remain unknown.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4040375     DOI: 10.1016/0741-8329(85)90027-8

Source DB:  PubMed          Journal:  Alcohol        ISSN: 0741-8329            Impact factor:   2.405


  5 in total

1.  The transduction of the signal for grape bud dormancy breaking induced by hydrogen cyanamide may involve the SNF-like protein kinase GDBRPK.

Authors:  E Or; I Vilozny; Y Eyal; A Ogrodovitch
Journal:  Plant Mol Biol       Date:  2000-07       Impact factor: 4.076

Review 2.  The pharmacology of nitroxyl (HNO) and its therapeutic potential: not just the Janus face of NO.

Authors:  Nazareno Paolocci; Matthew I Jackson; Brenda E Lopez; Katrina Miranda; Carlo G Tocchetti; David A Wink; Adrian J Hobbs; Jon M Fukuto
Journal:  Pharmacol Ther       Date:  2006-11-29       Impact factor: 12.310

Review 3.  A recent history of nitroxyl chemistry, pharmacology and therapeutic potential.

Authors:  Jon M Fukuto
Journal:  Br J Pharmacol       Date:  2018-07-01       Impact factor: 8.739

4.  DORMEX-hydrogen cyanamide poisoning.

Authors:  Sunil Holavanahalli Sheshadri; Uchil Sudhir; Shiva Kumar; Punith Kempegowda
Journal:  J Emerg Trauma Shock       Date:  2011-07

5.  HNO to NO Conversion Mechanism with Copper Zinc Superoxide Dismutase, Comparison with Heme Protein Mediated Conversions, and the Origin of Questionable Reversibility.

Authors:  Yelu Shi; Matthew A Michael; Yong Zhang
Journal:  Chemistry       Date:  2021-02-16       Impact factor: 5.236

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.